EVAR - Lombard Medical, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Lombard Medical, Inc.

4 Trident Park
Didcot OX11 7HJ
United Kingdom
44 12 3575 0800
http://www.lombardmedical.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees113

Key Executives

NameTitlePayExercisedAge
Mr. Kurt B. LemvighChief Exec. OfficerN/AN/A49
Dr. Peter PhillipsChief Technology Officer292.1kN/A58
Ms. Linda D'AbateVP of Global Clinical & Regulatory Affairs123.16kN/AN/A
Andrew DebbageVP of OperationsN/AN/AN/A
Mr. Jonathan HornsbyVP of Sales & MarketingN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company’s principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.

Corporate Governance

Lombard Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.